Vical, Inc.

Based in San Diego, California, Vical develops biopharmaceutical products based on patented naked DNA gene transfer technologies for the prevention and treatment of life-threatening diseases. We currently focus our development on innovative cancer therapies designed to induce an immune response against cancer cells without causing serious side effects. We have retained all rights to our internally developed cancer product candidates. Our lead candidates, Allovectin-7Žand Leuvectin, are both in late-stage clinical trials for multiple indications.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: